Showing 81 - 100 results of 388 for search '"Фармакокинетика и Фармакодинамика"', query time: 0.07s Refine Results
  1. 81
    Фармакодинамика и фармакокинетика нанонейрофармакологических препаратов

    Фармакодинамика и фармакокинетика нанонейрофармакологических препаратов

    Published 2012-03-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 82
    Bioequivalence studies Nipezam retard tablets, 400 mg (JSC «Himfarm», Kazakhstan) and Finlepsin® 400 retard tablets 400 mg («Pliva Krakow, SA Pharmaceutical company», Poland)

    Bioequivalence studies Nipezam retard tablets, 400 mg (JSC «Himfarm», Kazakhstan) and Finlepsin® 400 retard tablets 400 mg («Pliva Krakow, SA Pharmaceutical company», Poland) by A. K. Sariev, D. A. Abaimov, M. V. Tankevich, Y. . Budach, O. . Kurilov, S. A. Altinbekov, G. A. Dzholdygulov, V. N. Seryakov, K. S. Altinbekov

    Published 2014-04-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 83
    Применение терапевтического лекарственного мониторинга финлепсина в крови в клинической практике

    Применение терапевтического лекарственного мониторинга финлепсина в крови в клинической практике...

    Published 2020-04-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 84
    Estimation of the effectiveness of the vitamin and mineral complex of magnesium lactate and pyridoxine as a means of correcting the deviations of element homeostasis in young people living in the Ivanovo region

    Estimation of the effectiveness of the vitamin and mineral complex of magnesium lactate and pyridoxine as a means of correcting the deviations of element homeostasis in young peopl... by T. E. Bogacheva, A. G. Kalacheva, T. R. Grishina, O. A. Gromova

    Published 2018-02-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 85
    Study the pharmacokinetics and bioavailability in the creation of new original drugs peptide structures and their optimum dosage forms

    Study the pharmacokinetics and bioavailability in the creation of new original drugs peptide structures and their optimum dosage forms by E. V. Ivannikova, V. P. Zherdev, S. S. Boyko, E. V. Blynskaya, K. G. Turchinskaya, K. V. Alekseev

    Published 2013-09-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 86
    Study of acute toxicity of potential anxiolytic GML-1

    Study of acute toxicity of potential anxiolytic GML-1 by I. A. Miroshkina, A. V. Sorokina, A. V. Volkova, K. S. Kachalov, I. V. Alekseev, A. D. Zaharov, S. V. Alekseeva, A. D. Durnev

    Published 2019-01-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 87
    Factors, effecting on drug bioavailability

    Factors, effecting on drug bioavailability by P. . Bochkov, R. . Shevchenko, A. . Litvin, G. . Kolyvanov, V. . Zherdev

    Published 2020-04-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 88
    Effect of nerve growth factor dimeric mimetic GK-2 on microcirculation in skeletal muscle on the hind limb ischemia model in rats

    Effect of nerve growth factor dimeric mimetic GK-2 on microcirculation in skeletal muscle on the hind limb ischemia model in rats by I. B. Tsorin, A. O. Efimova, E. S. Pekeldina, M. B. Vititnova, S. A. Kryzhanovskii

    Published 2021-06-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 89
    The influence of the pharmacokinetics and bioavailability of cyclo-L-propylglycine to the manifestation of its main pharmacological effects in experimental animals

    The influence of the pharmacokinetics and bioavailability of cyclo-L-propylglycine to the manifestation of its main pharmacological effects in experimental animals by S. S. Boyko, K. N. Koljasnikova, V. P. Zherdev

    Published 2021-06-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 90
    Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats

    Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats by G. B. Kolyvanov, P. O. Bochkov, A. A. Litvin, R. V. Shevchenko, A. L. Podolko, V. P. Zherdev

    Published 2022-01-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 91
    Food-drug interactions: genotoxicological aspects

    Food-drug interactions: genotoxicological aspects by A. D. Durnev

    Published 2016-03-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 92
    Какие фосфолипиды «эссенциальнее»?

    Какие фосфолипиды «эссенциальнее»?

    Published 2020-04-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 93
    Comparative study of the effects of adamantane derivatives on the behavior of CD-1 mice with different phenotype of attention stability

    Comparative study of the effects of adamantane derivatives on the behavior of CD-1 mice with different phenotype of attention stability by N. A. Sukhorukova, R. M. Salimov, G. I. Kovalev

    Published 2022-05-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 94
    Dynamics of the cardioelectric field of rats under chronic exposure to doxorubicin during atrial depolarization

    Dynamics of the cardioelectric field of rats under chronic exposure to doxorubicin during atrial depolarization by S. L. Smirnova, O. V. Suslonova, I. M. Roshchevskaya

    Published 2022-02-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 95
    Популяционная фармакокинетика препарата метотрексат. Клинический мониторинг при лечении острого лимфобластного лейкоза и лимфом у детей

    Популяционная фармакокинетика препарата метотрексат. Клинический мониторинг при лечении острого лимфобластного лейкоза и лимфом у детей...

    Published 2020-04-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 96
    Isoform CYP1A2, as a part of the cytochrome P450 superfamily

    Isoform CYP1A2, as a part of the cytochrome P450 superfamily by Y. G. Novickaya, V. P. Zherdev, A. O. Viglinskaya, A. A. Litvin

    Published 2014-04-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 97
    Behavioral features of Wistar rats in models of autism spectrum disorders induced by prenatal or postnatal administration of sodium valproate

    Behavioral features of Wistar rats in models of autism spectrum disorders induced by prenatal or postnatal administration of sodium valproate by E. V. Savinkova, I. G. Kapitsa, T. A. Voronina

    Published 2024-08-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 98
    2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol): blood content in rats after intravenous administration and chemical resistance

    2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol): blood content in rats after intravenous administration and chemical resistance by V. A. Alexandrov, G. V. Tochilnikov, S. V. Shatik, A. N. Stukov, O. A. Beljaeva, E. V. Bashkatova, V. G. Dranishnikov, T. Yu. Semiglazova

    Published 2025-01-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 99
    Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>

    Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacte... by А. Yu. Savchenko, V. G. Kukes, M. S. Burenkov, G. V. Ramenskaya

    Published 2024-01-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 100
    Сardioprotective agents with biaromatic structure. Part 4. Potassium hERG channels blockers and modulators

    Сardioprotective agents with biaromatic structure. Part 4. Potassium hERG channels blockers and modulators by G. V. Mokrov

    Published 2023-01-01
    “…Фармакокинетика и Фармакодинамика…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: